Valuation: Dechra Pharmaceuticals

Market Cap 4.4B 5.92B 5.18B 4.78B 8.3B 571B 8.48B 57.1B 22.46B 279B 22.25B 21.76B 962B P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 4.83B 6.5B 5.68B 5.24B 9.11B 626B 9.31B 62.68B 24.65B 307B 24.42B 23.89B 1,056B EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
3 years 3,644
Extreme 3644
3,868
5 years 2,473.32
Extreme 2473.323
5,525
10 years 1,225
Extreme 1225
5,525
Manager TitleAgeSince
Chief Executive Officer - 2024-06-09
Director of Finance/CFO 46 2019-04-02
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 2019-10-29
Director/Board Member 68 2016-11-30
Director/Board Member 59 2019-01-31
Date Insider Type Main position Quantity % Market Cap.
1/15/24 Buy

Chief Executive Officer

627 0.0006%
1/15/24 Free

Chief Executive Officer

20,193 0.0177%
1/15/24 Buy

Chief Financial Officer

627 0.0006%

Financials

2022 2023
Net sales 682M 917M 802M 740M 1.29B 88.33B 1.31B 8.84B 3.48B 43.26B 3.44B 3.37B 149B 762M 1.02B 895M 826M 1.44B 98.66B 1.47B 9.87B 3.88B 48.32B 3.85B 3.76B 166B
Net income 58.2M 78.3M 68.42M 63.14M 110M 7.54B 112M 755M 297M 3.69B 294M 288M 12.71B -27.9M -37.53M -32.8M -30.27M -52.59M -3.61B -53.75M -362M -142M -1.77B -141M -138M -6.09B
Net Debt 208M 280M 245M 226M 392M 26.97B 401M 2.7B 1.06B 13.21B 1.05B 1.03B 45.48B 430M 579M 506M 467M 811M 55.72B 829M 5.58B 2.19B 27.29B 2.17B 2.13B 93.95B
Logo Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-